LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)

B.J. Monk, A. Oaknin, David M. O’Malley, M. Wilson, Domenica Lorusso, Shannon N. Westin, Amit M. Oza, Flora Zagouri, T.J. Herzog, Olga Mikheeva, Christine Parkinson, R.L. Coleman, Myong Cheol Lim, Anita Chudecka-Głaz, Ramez N. Eskander, Ilan Bruchim, Sharad Ghamande, Darrin Despain, K. Fujiwara, Rebecca Kristeleit